Compound ID | 1871
Synonym(s): CP-45,899
Class: Beta-lactamase inhibitor (penicillanic acid sulfone)
Details of activity: | Binds irreversibly to beta-lactamases, mainly class A enzymes. No intrinsic antibacterial activity except some antibacterial activity against Acinetobacter |
Combined with other compounds: | Yes |
Description: | Streptomyces natural product. Only available as a combination product, oral and parenteral application |
Institute where first reported: | Pfizer |
Year first mentioned: | 1978 |
Highest developmental phase: | Approved by FDA in 1986 |
Development status: | Approved, off-patent |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/130313 |
Guide to Pharmacology: | sulbactam |
Citations: |
|